These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

36 related articles for article (PubMed ID: 12946782)

  • 21. Prostate Cancer Screening and the Associated Controversy.
    Tabayoyong W; Abouassaly R
    Surg Clin North Am; 2015 Oct; 95(5):1023-39. PubMed ID: 26315521
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Prostatic specific antigen in practice in 1997].
    Salomon L; Colombel M; Patard JJ; Chopin D; Abbou CC
    Ann Urol (Paris); 1998; 32(2):69-72. PubMed ID: 9599634
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prostate specific antigen: a useful screening test?
    Concato J
    Cancer J; 2000 Apr; 6 Suppl 2():S188-92. PubMed ID: 10803835
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Should men over the age of 65 years receive PSA screening? Argument in favor.
    Whitson JM; Konety BR
    Nat Clin Pract Urol; 2008 May; 5(5):230-1. PubMed ID: 18349861
    [No Abstract]   [Full Text] [Related]  

  • 25. What to do with an abnormal PSA test.
    Loeb S; Catalona WJ
    Oncologist; 2008 Mar; 13(3):299-305. PubMed ID: 18378540
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prostate cancer. When to offer screening in the primary care setting.
    Gambert SR
    Geriatrics; 2001 Jan; 56(1):22-6, 29-31. PubMed ID: 11196336
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Early detection of prostate cancer: is PSA a reliable option?
    Okihara K; Babaian RJ
    Tex Med; 2001 Feb; 97(2):59-62. PubMed ID: 11233061
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Early detection of prostate cancer. Role of prostate-specific antigen.
    Prabhakaran VM
    Can Fam Physician; 1996 Apr; 42():709-12. PubMed ID: 8653039
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The PSA test does not hold for screening. Good--but not good enough].
    Holmström B; Johansson M; Bratt O; Stattin P
    Lakartidningen; 2010 Feb 17-23; 107(7):436, 438-9. PubMed ID: 20384076
    [No Abstract]   [Full Text] [Related]  

  • 30. Prostate-Specific Antigen (PSA)-Based Population Screening for Prostate Cancer: An Evidence-Based Analysis.
    Pron G
    Ont Health Technol Assess Ser; 2015; 15(10):1-64. PubMed ID: 26366236
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Screening and early detection of prostate cancer.
    Schröder FH; Alexander FE; Bangma CH; Hugosson J; Smith DS
    Prostate; 2000 Aug; 44(3):255-63. PubMed ID: 10906743
    [No Abstract]   [Full Text] [Related]  

  • 32. Editorial panel on informed consent for PSA screening.
    Ramsden AR; Chodak G
    Urology; 2003 Sep; 62(3):589. PubMed ID: 12946782
    [No Abstract]   [Full Text] [Related]  

  • 33. Promoting informed decision making about prostate cancer screening.
    Chan EC
    Compr Ther; 2001; 27(3):195-201. PubMed ID: 11569319
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Screening for prostate cancer in 2006: PSA in the 21st century.
    Maroni PD; Crawford ED
    N C Med J; 2006; 67(2):136-9. PubMed ID: 16752718
    [No Abstract]   [Full Text] [Related]  

  • 35. Part 2: Patient information, informed decision-making and the psycho-social impact of prostate-specific antigen testing.
    Hewitson P; Austoker J
    BJU Int; 2005 Apr; 95 Suppl 3():16-32. PubMed ID: 15844284
    [No Abstract]   [Full Text] [Related]  

  • 36. Screening for prostate cancer: informing men about their options.
    Mahon SM
    Clin J Oncol Nurs; 2005 Oct; 9(5):625-7. PubMed ID: 16235590
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 2.